Legal & General Group’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.89M | Sell |
|
|||||
|
2025
Q1 | $6.2M | Buy |
|
|||||
|
2024
Q4 | $7.13M | Sell |
|
|||||
|
2024
Q3 | $6.99M | Buy |
|
|||||
|
2024
Q2 | $5.64M | Buy |
|
|||||
|
2024
Q1 | $4.58M | Buy |
|
|||||
|
2023
Q4 | $3.3M | Sell |
|
|||||
|
2023
Q3 | $3.45M | Sell |
|
|||||
|
2023
Q2 | $3.3M | Buy |
|
|||||
|
2023
Q1 | $864K | Buy |
|
|||||
|
2022
Q4 | $811K | Buy |
|
|||||
|
2022
Q3 | $315K | Buy |
|